PK-061

N/A

Report date: 2024/11/22 10:46:46

Base Information

Drug NamePK-061
Drug Alias NamePK-061PK061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid protein aggregation inhibitorsMicrotubule-associated protein tau modulators
TargetsAmyloidMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPharmaKure Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPharmaKure Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A